A Natural History Observation and Registry Study of Macular Telangiectasia Type
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Scottsdale/Phoenix, Arizona: 18-005303
Sponsor Protocol Number: 18-005303
About this study
The purpose of this study is to identify persons with MacTel Type 2, and their affected family members to create a registry of persons with MacTel Type 2. This registry will be used to study participants with MacTel Type 2 now and may be used in the future to identify persons to be in a study that may help find a way to prevent or treat this eye condition. We also wish to keep in contact with persons who have been told by their MacTel doctor that they have MacTel Type 2.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
Registry Probands
- Must have a confirmed clinical diagnosis of MacTel Type 2.
- Must be 18 years of age or older.
- Should not have diabetic retinopathy with 10 or more microaneurysms.
- Have no confounding ocular conditions that may now or in the future complicate the evaluation of MacTel Type 2.
- Participant must be offered sufficient opportunity to review and to understand the informed consent form, agree to the form’s contents and sign the informed consent.
Family Members
- Family members of any proband who are of the age approved by the IRB/IEC at the clinic where the family member will be seen may consent for screening. Halfsiblings are allowed to participate.
- If confirmed to be affected with MacTel Type 2, the Family Member may consent to be enrolled in the registry.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Scottsdale/Phoenix, Ariz.
Mayo Clinic principal investigator Odette Houghton, M.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available